SCHEMBL13288583

SCHEMBL13288583

C#CCOc1ccc(CCC(=O)NC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 3/20 0.44
PCNA P12004 1/20 0.44
GAA P10253 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
ATM Q13315 1/20 0.43
F2RL1 P55085 1/20 0.43
FFAR1 O14842 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
GSTP1 P09211 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2868376 0.84 ADRB2 (0.53) POLBALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL1495264 0.81 FFAR1 (0.59) LMNAL3MBTL1FFAR1
SCHEMBL19522848 0.80 PCNA (0.52) POLBALDH1A1KMT2APCNAGAA
SCHEMBL14387746 0.79 HDAC1 (0.53) POLBALDH1A1PCNAHSD17B1HSD17B2
SCHEMBL11969671 0.78 ACACB (0.65)
SCHEMBL12228278 0.78 F2RL1 (0.69) POLBALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL10138384 0.78 PLK1 (0.51) POLBALDH1A1GAALMNAL3MBTL1
SCHEMBL20382474 0.75 LMNA (0.51) ALDH1A1KMT2AMEN1LMNAL3MBTL1
SCHEMBL5889857 0.74 ACACB (0.50) POLBALDH1A1
SCHEMBL9155228 0.74 CA12 (0.47) ALDH1A1KMT2AMEN1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158850-A1 DENDRIMER BASED MODULAR PLATFORMS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100158850-A1 DENDRIMER BASED MODULAR PLATFORMS ERBB2, ERBB3, ADGRE5 POLB 3608/4885ALDH1A1 3681/4885KMT2A 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.